Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Elmos Semiconductor Aktie 810140 / DE0005677108

04.11.2025 07:42:03

EQS-News: Elmos Semiconductor SE: Encouraging order development and strong free cash flow in the third quarter of 2025 – free cash flow guidance for the full year increased

EQS-News: Elmos Semiconductor SE / Key word(s): Quarter Results
Elmos Semiconductor SE: Encouraging order development and strong free cash flow in the third quarter of 2025 – free cash flow guidance for the full year increased

04.11.2025 / 07:42 CET/CEST
The issuer is solely responsible for the content of this announcement.


Elmos Semiconductor SE: Encouraging order development and strong free cash flow in the third quarter of 2025 – free cash flow guidance for the full year increased

Sales reach 140.8 million Euro in the third quarter 2025 – EBIT margin at 22.5% with significantly improved adjusted free cash flow of 32.5 million Euro

Leverkusen, November 4, 2025: Elmos Semiconductor SE (FSE: ELG) showed a robust development in the third quarter of 2025 and managed to significantly improve EBIT and the adjusted free cash flow compared to the previous quarter. Due to the migration to the new SAP S/4HANA system and a corresponding shift of orders from the third to the fourth quarter, sales were slightly down quarter-on-quarter at 140.8 million Euro (Q2 2025: 145.7 million Euro). The system-related shift in sales has no impact on the sales guidance for the full year 2025. Earnings before interest and taxes (EBIT) in the third quarter were 31.7 million Euro, above the previous quarter (Q2 2025: 30.1 million Euro). The EBIT margin was also above the previous quarter at 22.5% (Q2 2025: 20.6%). Capital expenditures for property, plant and equipment and intangible assets less capitalized development expenses amounted to 5.9 million Euro or 4.2% of sales, remaining at the low level of the previous quarter (Q2 2025: 4.6 million Euro or 3.2% of sales). At 32.5 million Euro or 23.1% of sales, adjusted free cash flow developed very positively in the third quarter. In the first nine months, adjusted free cash flow reached 54.6 million Euro or 13.2% of sales.

“Order intake continued to develop positively in the past quarter, and the signs that inventory adjustments are coming to an end and that order volumes are returning to normal levels are clearly visible,” explains Dr. Arne Schneider, CEO of Elmos Semiconductor SE. “We are continuing to work consistently on implementing our operational and strategic agenda for profitable growth and higher cash generation. Thanks to our innovative product portfolio and our excellent positioning as a fabless company, we expect a strong final quarter and are also very confident about the coming year,” Dr. Arne Schneider continues.

For the fiscal year 2025, Elmos expects sales of 580 million Euro ± 20 million Euro. The company continues to expect an EBIT margin in the lower half of the guidance range of 23% ± 3 percentage points of sales. Elmos forecasts capital expenditures in property, plant and equipment and intangible assets less capitalized development expenses in the lower half of the guidance range of 7% ± 2 percentage points of sales. For fiscal year 2025, Elmos now expects a positive adjusted free cash flow of 10% ± 2 percentage points of sales (previously: 7% ± 2 percentage points of sales) and thus significantly above the level of the prior year. The guidance is based on an exchange rate of 1.15 EUR/USD.

Overview of the financial figures
Figures according to IFRS (in million Euro or percent unless otherwise indicated):

  Q3/25 Q3/24 Diff. 9M/25 9M/24 Diff.
Sales 140.8 156.6 -10.1% 413.3 435.4 -5.1%
Gross profit 61.3 73.6 -16.7% 176.4 200.4 -12.0%
Gross margin in % 43.6% 47.0%   42.7% 46.0%  
Research and development 14.2 12.7 11.6% 49.0 45.8 6.8%
Operating Income 32.2 46.2 -30.3% 85.7 112.3 -23.7%
EBIT 31.7 39.9 -20.6% 87.4 109.7 -20.3%
EBIT margin in % 22.5% 25.5%   21.1% 25.2%  
Consolidated net income after
non-controlling interests

23.6

25.5

-7.6%

69.7

74.4

-6.3%
Earnings per share (Euro) 1.37 1.49 -7.9% 4.06 4.34 -6.5%
Capital expenditures 5.9 5.9 -0.9% 24.0 40.6 -40.9%
Capital expenditures in % of sales 4.2% 3.8%   5.8% 9.3%  
Adjusted free cash flow 32.5 45.5 -28.4% 54.6 -1.7 n/a
Adjusted free cash flow in % of sales 23.1% 29.0%   13.2% -0.4%  

 Definitions of selected financial indicators
- Capital expenditures: Capital expenditures for intangible assets and property, plant and equipment less capitalized development expenses
- Adjusted free cash flow: Cash flow from operating activities less capital expenditures for/plus disposal of intangible assets and property, plant and equipment (including payments from changes in the scope of consolidation) 
- Further information on the key figures used can be found in the Annual Report 2024 at www.elmos.com 

Quarterly statement Q3 2025
Further information on the third quarter 2025 and the first nine months of 2025 of Elmos Semiconductor SE can be found in the quarterly statement Q3 2025. This statement is available at www.elmos.com. Elmos will hold a conference call (in English) for analysts and investors on November 4, 2025 at 10:00 a.m. (CET). The conference call will be available later on the website.

Contact
Elmos Semiconductor SE
Ralf Hoppe, CIR (Corporate Investor Relations, Communications & ESG)
Mobile: +49 151 5383 7905
Email: invest@elmos.com

About Elmos
Elmos has been developing intelligent microchip solutions for over 40 years, primarily for the automotive industry. As a fabless company and specialist for analog mixed-signal ICs, Elmos makes the mobility of the future safer, more comfortable and more efficient. The innovative products of Elmos enable reliable driver assistance systems, intelligent sensors, efficient motors and new LED lighting concepts in modern vehicles. As a market leader in cutting-edge applications, Elmos is powering global megatrends such as autonomous driving, electromobility and software-defined vehicles.

Note
This release contains forward-looking statements that are based on assumptions and estimates made by the Elmos management. Even though we assume the underlying expectations of the forward-looking statements to be realistic, we cannot guarantee the expectations will prove right. The assumptions may carry risks and uncertainties, and as a result actual events may differ materially from the forward-looking statements. Among the factors that could cause such differences are changes in general economic and business conditions, fluctuations of exchange rates and interest rates, the introduction of competing products, lack of acceptance of new products, and changes in business strategy. Elmos neither intends nor assumes any obligation to update its statements with respect to future events.



04.11.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Elmos Semiconductor SE
Werkstättenstrasse 18
51379 Leverkusen
Germany
Phone: +49 (0) 2171 / 40 183-0
E-mail: invest@elmos.com
Internet: http://www.elmos.com
ISIN: DE0005677108
WKN: 567710
Indices: SDAX, TecDax
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2223146

 
End of News EQS News Service

2223146  04.11.2025 CET/CEST

Analysen zu Elmos Semiconductor

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
05.11.25 Elmos Semiconductor Buy Warburg Research
05.11.25 Elmos Semiconductor Hold Deutsche Bank AG
30.10.25 Elmos Semiconductor Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
02.10.25 Elmos Semiconductor Buy Warburg Research
23.09.25 Elmos Semiconductor Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Mittwoch um 18 Uhr live: Die Illusion der Erinnerung - Wie du Denkfehler im Trading vermeidest

Erfahrung ist wertvoll - doch Erinnerungen sind trügerisch. Sie verzerren, ergänzen oder lassen Details weg, bis ein falsches Bild entsteht. Dieses Webinar zeigt, warum das Gehirn keine objektive Aufzeichnung liefert und wie diese Verzerrungen Trading-Entscheidungen unbewusst beeinflussen.

Schnell noch Plätze sichern!

Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer

Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉

Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.

💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Abnehmspritzen – Ist der Hype vorbei? – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’974.31 19.37 BP9SUU
Short 13’215.46 13.98 BU9S6U
Short 13’724.19 8.85 B19SNU
SMI-Kurs: 12’465.39 10.11.2025 17:30:00
Long 11’962.62 19.84 SNLBQU
Long 11’690.01 13.82 SSTBSU
Long 11’209.46 8.98 SQZB6U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com